Sartorius Stedim Biotech postpones Annual Shareholders' Meeting
Sartorius Stedim Biotech S.A. will postpone its Annual General Shareholders’ Meeting formerly scheduled for March 24, 2020, to a later date due to the coronavirus pandemic and the associated restrictions imposed on travel and meetings. This was resolved by the Board of Directors of the company on March 17, 2020.
As a result of the cancelation of the Annual General Shareholders’ Meeting on March 24, 2020, the vote on the resolution on the assignment of the financial result for the year ended December 31, 2019, and the payment of dividends, among other things, will also be deferred.
The 2020 Annual General Shareholders’ Meeting is to be scheduled for a new date within six months after the close of the fiscal year ending on December 31, 2019 as provided for under the French Commercial Law. Sartorius Stedim Biotech will inform its shareholders and the public in a timely manner about its further planning.
Documents
1. Information to Shareholders
- 1.1 Notice of the meeting PDF | 937.6 KB
- 1.2 Shareholders' convening guide PDF | 3.8 MB
- 1.3 Vote form PDF | 1.7 MB
- 1.4 Request of documents by a shareholder PDF | 269.4 KB
- 1.5 Resolutions PDF | 920.9 KB
2. Documents to be presented to the Annual Combined General Meeting
- 2.1 Management Report of Sartorius Stedim Biotech S.A. PDF | 648.0 KB
- 2.2 Group Management Report PDF | 89.7 KB
- 2.3 Board of Director's Report on Corporate Governance PDF | 317.1 KB
- 2.4 Annual Financial Statements of Sartorius Stedim Biotech S.A. PDF | 158.5 KB
- 2.5 Consolidated financial statements of Sartorius Stedim Biotech Group PDF | 418.5 KB
- 2.6 Statutory auditors' report on the annual financial statement of Sartorius Stedim Biotech S.A. for the financial year closed 31.12.2019 PDF | 55.2 KB
- 2.7 Statutory auditors' report on the consolidated statements of Sartorius Stedim Biotech Group for the financial year closed 31.12.2019 PDF | 60.7 KB
- 2.8 Statutory auditors' report on the information disclosed in accordance with article L. 225-38 of the French Commercial Code PDF | 521.3 KB
- 2.9 Information regarding the Board of Directors’ members PDF | 161.8 KB
- 2.10 Delegations granted to the Board of Directors by the Shareholders’ Meeting PDF | 43.8 KB
- 2.11 Total number of shares and voting rights making up the issued capital PDF | 118.9 KB